Novel pain signalling assays for the development of cannabinoid-based medicines
Novel pain signalling assays for the development of cannabinoid-based medicines You can download this article as .pdf pdf icon copy Novel pain signalling assays for the development of cannabinoid-based medicines Oval Partnership applies cutting edge assays to understand the mechanisms behind active components of cannabis and their effects on pain. NEWCASTLE, AUSTRALIA – Friday, 18